Lv1
64 积分 2024-11-13 加入
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial
3天前
已完结
The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
8天前
已完结
Cervical cancer
12天前
已完结
Extranodal Marginal Zone Lymphoma of the Central Nervous System
17天前
已完结
Primary central nervous system marginal zone lymphoma
17天前
已完结
Meta‐analysis evaluating the efficacy and safety of various Bruton tyrosine kinase (BTK) inhibitors for central nervous system lymphoma: Novel covalent BTK inhibitors, except for ibrutinib, also demonstrate good efficacy in the treatment of primary central nervous system lymphoma
25天前
已完结
A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma
26天前
已关闭
In vivo CAR T cell generation to treat cancer and autoimmune disease
1个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Relapsed / Refractory Marginal Zone Lymphoma: Results from Phase 1/2 BRUIN Study
2个月前
已完结
皖公网安备34019202002308
